Trial
NCT04044560
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of British Columbia
Collaborators
Amgen
Condition
B-cell Adult Acute Lymphoblastic Leukemia
Intervention
blinatumomab
Why stopped
Slow enrolment, loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-21